Work

Engineering of CD19-Specific Chimeric Antigen Receptor T Cells with the Integrin CD103 Results in Augmented Therapeutic Efficacy Against Human Lymphoma in a Preclinical Model

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-117354

Authors: Hongxing Sun, Shan He, Lijun Meng, Ying Wang, Hanghang Zhang, Yongnian Liu, Jian Wang, Min Tao, Stefan Klaus Barta, Essel D. Al-Saleem, Henry C. Fung, Jean-Pierre Issa, Leizhen Zheng, Yi Zhang

Institutions: Temple University, Soochow University, First Affiliated Hospital of Soochow University, Fox Chase Cancer Center, Shanghai Jiao Tong University, XinHua Hospital

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2911524113

Cites:

Cited by: 1

Related to: 10